Background and purpose: Transmembrane proline ( P) residues in family A G protein- coupled receptors ( GPCRs) form functionally important kinks in their helices. These residues are little studied in family B GPCRs but experiments with the VPAC1 receptor and calcitonin receptor- like receptor ( CL) show parallels with family A receptors. We sought to determine the function of these residues in the insert negative form of the human calcitonin receptor, a close relative of CL. Experimental approach: Proline residues within the transmembrane domains of the calcitonin receptor ( P246, P249, P280, P326, P336) were individually mutated to alanine ( A) using site- directed mutagenesis. Receptors were transiently transfected into Cos- 7 cells using polyethylenimine and salmon and human calcitonin- induced cAMP responses measured. Salmon and human calcitonin competition binding experiments were also performed and receptor cell- surface expression assessed by whole cell ELISA. Key results: P246A, P249A and P280A were wild- type in terms of human calcitonin- induced cAMP activation. P326A and P336A had reduced function ( 165 and 12- fold, respectively). In membranes, human calcitonin binding was not detectable for any mutant receptor but in whole cells, binding was detected for all mutants apart from P326A. Salmon calcitonin activated mutant and wild- type receptors equally, although Bmax values were reduced for all mutants apart from P326A. Conclusions and Implications: P326 and P336 are important for the function of human calcitonin receptors and are likely to be involved in generating receptor conformations appropriate for agonist-specific effects were observed implying distinct conformat human calcitonin receptor. effects were observed, implying distinct conformations of the human calcitonin receptor.
机构:
Temple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Temple Univ, Dept Pharmacol, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USATemple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Chiu, Yi-Ting
Chen, Chongguang
论文数: 0引用数: 0
h-index: 0
机构:
Temple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Temple Univ, Dept Pharmacol, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USATemple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Chen, Chongguang
Yu, Daohai
论文数: 0引用数: 0
h-index: 0
机构:
Temple Univ, Dept Clin Sci, Lewis Katz Sch Med, Philadelphia, PA 19122 USATemple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Yu, Daohai
论文数: 引用数:
h-index:
机构:
Schulz, Stefan
Liu-Chen, Lee-Yuan
论文数: 0引用数: 0
h-index: 0
机构:
Temple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
Temple Univ, Dept Pharmacol, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USATemple Univ, Ctr Subst Abuse Res, Lewis Katz Sch Med, 3500 North Broad St,MERB 851, Philadelphia, PA 19140 USA
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Zhang, Xuan
Du, Xiao-Na
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Du, Xiao-Na
Zhang, Guo-Hong
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Zhang, Guo-Hong
Jia, Zhan-Feng
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Jia, Zhan-Feng
Chen, Xing-Juan
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Chen, Xing-Juan
Huang, Dong-Yang
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Huang, Dong-Yang
Liu, Bo-Yi
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
Liu, Bo-Yi
Zhang, Hai-Lin
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R ChinaHebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China
机构:
Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USARutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
Cote, Samantha R.
Kuzhikandathil, Eldo V.
论文数: 0引用数: 0
h-index: 0
机构:
Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USARutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA